Celgene Corporation (Nasdaq: CELG) to Ring The Nasdaq Stock Market Opening Bell
September 06 2017 - 9:00AM
What: Celgene Corporation (Nasdaq:CELG), a
global biopharmaceutical company engaged in the discovery,
development and commercialization of innovative therapies for the
treatment of cancer and immune-inflammatory related diseases, will
visit the Nasdaq MarketSite in Times Square.
In honor of the occasion, Mark Alles, Chief Executive
Officer will ring the Opening Bell.
Where:Nasdaq MarketSite – 4 Times Square – 43rd
& Broadway – Broadcast Studio
When:Thursday, September 7, 2017 – 9:15 a.m. to
9:30 a.m. ET
Celgene Corporation Media Contact:Brian
Gill908-673-9530bgill@celgene.com
Nasdaq MarketSite:Emily Pan(646)
441-5120emily.pan@nasdaq.com
Feed Information:Fiber Line (Encompass
Waterfront): 4463
Gal 3C/06C 95.05 degrees West 18 mhz Lower DL 3811 Vertical FEC
3/4 SR 13.235 DR 18.295411 MOD 4:2:0 DVBS QPSK
Social Media:For multimedia features such as
exclusive content, photo postings, status updates and video of bell
ceremonies, please visit our Facebook
page:http://www.facebook.com/NASDAQ.
For photos from ceremonies and events, please visit our
Instagram page:http://instagram.com/nasdaq
For livestream of ceremonies and events, please visit our
YouTube page:http://www.youtube.com/nasdaq/live
For news tweets, please visit our Twitter
page:http://twitter.com/nasdaq
For exciting viral content and ceremony photos, please visit our
Tumblr page:http://nasdaq.tumblr.com/
Webcast: A live stream of the Nasdaq Opening
Bell will be available at: https://new.livestream.com/nasdaq/live
or http://www.nasdaq.com/about/marketsitetowervideo.asx
Photos: To obtain a hi-resolution photograph of
the Market Open, please go to
http://business.nasdaq.com/discover/market-bell-ceremonies and
click on the market open of your choice.
About Celgene CorporationCelgene Corporation,
headquartered in Summit, New Jersey, is an integrated global
biopharmaceutical company engaged primarily in the discovery,
development and commercialization of innovative therapies for the
treatment of cancer and inflammatory diseases through
next-generation solutions in protein homeostasis, immuno-oncology,
epigenetics, immunology and neuro-inflammation. For more
information, please visit www.celgene.com. Follow Celgene on social
media: @Celgene, Pinterest, LinkedIn, Facebook and YouTube.
About Nasdaq-100 Index®The Nasdaq-100 Index,
launched in January 1985, is one of the most widely followed
benchmarks in the world. The Nasdaq-100 Index is the basis of the
PowerShares QQQ Trust (Nasdaq:QQQ) which aims to provide investment
results that, before expenses, correspond with the Nasdaq-100
Index's performance. In addition, options, futures and structured
products based on the Nasdaq-100 Index and the PowerShares QQQ
Trust trade on various exchanges.
About Nasdaq:Nasdaq (Nasdaq:NDAQ) is a leading
global provider of trading, clearing, exchange technology, listing,
information and public company services. Through its diverse
portfolio of solutions, Nasdaq enables customers to plan, optimize
and execute their business vision with confidence, using proven
technologies that provide transparency and insight for navigating
today's global capital markets. As the creator of the world's first
electronic stock market, its technology powers more than 90
marketplaces in 50 countries, and 1 in 10 of the world's securities
transactions. Nasdaq is home to approximately 3,900 total listings
with a market value of approximately $12 trillion. To learn more,
visit: http://business.nasdaq.com
-NDAQA-
Celgene (NASDAQ:CELG)
Historical Stock Chart
From Apr 2024 to May 2024
Celgene (NASDAQ:CELG)
Historical Stock Chart
From May 2023 to May 2024